Dolby Laboratories Stock Performance
| DLB Stock | USD 75.35 0.27 0.36% |
Dolby Laboratories has a performance score of 5 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.88, which means possible diversification benefits within a given portfolio. Dolby Laboratories returns are very sensitive to returns on the market. As the market goes up or down, Dolby Laboratories is expected to follow. Dolby Laboratories right now shows a risk of 1.09%. Please confirm Dolby Laboratories jensen alpha, potential upside, accumulation distribution, as well as the relationship between the treynor ratio and expected short fall , to decide if Dolby Laboratories will be following its price patterns.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Dolby Laboratories are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong essential indicators, Dolby Laboratories is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors. ...more
Actual Historical Performance (%)
One Day Return (0.36) | Five Day Return 1.2 | Year To Date Return (3.14) | Ten Year Return 100.93 | All Time Return 210.08 |
Forward Dividend Yield 0.0178 | Payout Ratio | Forward Dividend Rate 1.32 | Dividend Date 2025-05-21 | Ex Dividend Date 2025-05-13 |
1 | Acquisition by Kevin Yeaman of 54425 shares of Dolby Laboratories subject to Rule 16b-3 | 04/25/2025 |
2 | Point72 Hong Kong Ltd Buys Shares of 3,544 Dolby Laboratories, Inc. - MarketBeat | 05/19/2025 |
| Dolby Laboratories dividend paid on 21st of May 2025 | 05/21/2025 |
3 | Disposition of 350 shares by Mark Sherman of Dolby Laboratories at 74.97 subject to Rule 16b-3 | 05/30/2025 |
4 | Libertarians ditch party to join Trumps GOP | 06/17/2025 |
5 | Cloud AI Today - Botpress Secures 25M To Enhance AI Agents Infrastructure | 06/24/2025 |
6 | Has Dolby Laboratories Drawn Market Focus On The SP 500 Index | 06/27/2025 |
7 | Dolby Laboratories versus Sony Critical Review | 07/01/2025 |
8 | Rare discount alert The Sonos Beam Gen 2 Dolby Atmos soundbar is at a near-record low price this Prime Day - grab it while you can | 07/08/2025 |
9 | At this Prime Day price, the Sonos Arc is the best all-in-one Dolby Atmos soundbar you can buy | 07/10/2025 |
10 | Hurry These genuinely awesome Amazon Prime Day soundbar deals end tonight save on ultra-cheap models up to premium Dolby Atmos systems | 07/11/2025 |
11 | Disposition of 14875 shares by Kevin Yeaman of Dolby Laboratories at 64.6 subject to Rule 16b-3 | 07/15/2025 |
12 | Disposition of 2491 shares by Kevin Yeaman of Dolby Laboratories at 64.6 subject to Rule 16b-3 | 07/16/2025 |
| Begin Period Cash Flow | 818 M | |
| Total Cashflows From Investing Activities | -286.3 M |
Dolby Laboratories Relative Risk vs. Return Landscape
If you would invest 7,241 in Dolby Laboratories on April 22, 2025 and sell it today you would earn a total of 294.00 from holding Dolby Laboratories or generate 4.06% return on investment over 90 days. Dolby Laboratories is generating 0.0701% of daily returns assuming volatility of 1.0935% on return distribution over 90 days investment horizon. In other words, 9% of stocks are less volatile than Dolby, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Dolby Laboratories Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Dolby Laboratories' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Dolby Laboratories, and traders can use it to determine the average amount a Dolby Laboratories' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0641
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | DLB | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.09 actual daily | 9 91% of assets are more volatile |
Expected Return
| 0.07 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 5 95% of assets perform better |
Based on monthly moving average Dolby Laboratories is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Dolby Laboratories by adding it to a well-diversified portfolio.
Dolby Laboratories Fundamentals Growth
Dolby Stock prices reflect investors' perceptions of the future prospects and financial health of Dolby Laboratories, and Dolby Laboratories fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Dolby Stock performance.
| Return On Equity | 0.1 | ||||
| Return On Asset | 0.0564 | ||||
| Profit Margin | 0.19 % | ||||
| Operating Margin | 0.30 % | ||||
| Current Valuation | 6.65 B | ||||
| Shares Outstanding | 61.41 M | ||||
| Price To Earning | 23.36 X | ||||
| Price To Book | 2.81 X | ||||
| Price To Sales | 5.48 X | ||||
| Revenue | 1.27 B | ||||
| Gross Profit | 1.17 B | ||||
| EBITDA | 258.33 M | ||||
| Net Income | 261.82 M | ||||
| Cash And Equivalents | 482.05 M | ||||
| Cash Per Share | 10.40 X | ||||
| Total Debt | 46.99 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 5.27 X | ||||
| Book Value Per Share | 26.79 X | ||||
| Cash Flow From Operations | 327.25 M | ||||
| Earnings Per Share | 2.64 X | ||||
| Market Capitalization | 7.24 B | ||||
| Total Asset | 3.11 B | ||||
| Retained Earnings | 2.5 B | ||||
| Working Capital | 776.58 M | ||||
| Current Asset | 759.73 M | ||||
| Current Liabilities | 213.08 M | ||||
About Dolby Laboratories Performance
By analyzing Dolby Laboratories' fundamental ratios, stakeholders can gain valuable insights into Dolby Laboratories' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Dolby Laboratories has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Dolby Laboratories has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 60.80 | 50.94 | |
| Return On Tangible Assets | 0.08 | 0.14 | |
| Return On Capital Employed | 0.09 | 0.08 | |
| Return On Assets | 0.07 | 0.12 | |
| Return On Equity | 0.08 | 0.15 |
Things to note about Dolby Laboratories performance evaluation
Checking the ongoing alerts about Dolby Laboratories for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Dolby Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Over 96.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from MacroaxisInsider: Disposition of 2491 shares by Kevin Yeaman of Dolby Laboratories at 64.6 subject to Rule 16b-3 |
- Analyzing Dolby Laboratories' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Dolby Laboratories' stock is overvalued or undervalued compared to its peers.
- Examining Dolby Laboratories' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Dolby Laboratories' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Dolby Laboratories' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Dolby Laboratories' stock. These opinions can provide insight into Dolby Laboratories' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Dolby Stock analysis
When running Dolby Laboratories' price analysis, check to measure Dolby Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dolby Laboratories is operating at the current time. Most of Dolby Laboratories' value examination focuses on studying past and present price action to predict the probability of Dolby Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dolby Laboratories' price. Additionally, you may evaluate how the addition of Dolby Laboratories to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |